000			02249 a2200613 4500
005			20250513102811.0
264		0	_c19970203
008			199702s 0 0 eng d
022			_a0934-9723
024	7		_a10.1007/BF01709367 _2doi
040			_aNLM _beng _cNLM
100	1		_aThompson, K A
245	0	0	_aResults of a double-blind placebo-controlled study of the double-stranded RNA drug polyI:polyC12U in the treatment of HIV infection. _h[electronic resource]
260			_bEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology _cJul 1996
300			_a580-7 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
650	0	4	_aAcquired Immunodeficiency Syndrome _xetiology
650	0	4	_aAdult
650	0	4	_aAnti-HIV Agents _xadverse effects
650	0	4	_aAntiviral Agents _xadverse effects
650	0	4	_aCD4 Lymphocyte Count
650	0	4	_aCandida albicans _ximmunology
650	0	4	_aCross-Over Studies
650	0	4	_aDisease Progression
650	0	4	_aDouble-Blind Method
650	0	4	_aDrug Hypersensitivity
650	0	4	_aDrug Therapy, Combination
650	0	4	_aFemale
650	0	4	_aHIV Core Protein p24 _xanalysis
650	0	4	_aHIV Infections _xdrug therapy
650	0	4	_aHumans
650	0	4	_aHypersensitivity, Delayed
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMumps _ximmunology
650	0	4	_aPoly I-C _xadverse effects
650	0	4	_aPoly U _xadverse effects
650	0	4	_aRNA, Double-Stranded
650	0	4	_aSkin Tests
650	0	4	_aTetanus _ximmunology
650	0	4	_aTrichophyton _ximmunology
650	0	4	_aZidovudine _xadverse effects
700	1		_aStrayer, D R
700	1		_aSalvato, P D
700	1		_aThompson, C E
700	1		_aKlimas, N
700	1		_aMolavi, A
700	1		_aHamill, A K
700	1		_aZheng, Z
700	1		_aVentura, D
700	1		_aCarter, W A
773	0		_tEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology _gvol. 15 _gno. 7 _gp. 580-7
856	4	0	_uhttps://doi.org/10.1007/BF01709367 _zAvailable from publisher's website
999			_c8866770 _d8866770